INDIANAPOLIS, June 15, 2020 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved Lyumjev ™ (insulin lispro-aabc injection, 100 units/mL and 200 units/mL), Eli Lilly and Company's ...

Eli Lilly & Company LLY announced plans to launch lower-priced versions of two of its insulin product, Humalog – Humalog Mix75/25 KwikPen and Humalog Junior KwikPen. The list price of these low-priced ...

Lower-priced versions of Humalog Mix 75/25 KwikPen (insulin lispro protamine and insulin lispro injectable suspension 100Units/mL) and Humalog Junior KwikPen (insulin lispro injection 100Units/mL) ...

President Joe Biden brought up that cost cap during his annual State of the Union address last month. He called for insulin costs for everyone to be capped at $35. This Wednesday, March 1, 2023 photo ...

Lilly has expanded its insulin affordability options for people with diabetes available through the Lilly Diabetes Solution Center. The Lilly Insulin Value Program allows anyone with commercial ...

When Erin Gilmer filled her insulin prescription at a Denver-area Walgreens in January, she paid $8.50. U.S. taxpayers paid another $280.51. "It eats at me to know that taxpayer money is being wasted, ...

This week, the FDA approved LYUMJEV (insulin lispro-aabc), a new insulin lispro product by Lilly. LYUMJEV is a formulation of insulin lispro, developed to speed the absorption of insulin into the ...

The list price is $137.35 per vial. This story is from Kaiser Health News When Erin Gilmer filled her insulin prescription at a Denver-area Walgreens in January, she paid $8.50. U.S. taxpayers paid ...

Eli Lilly will cut prices for some older insulins later this year and immediately give more patients access to a cap on the costs they pay to fill prescriptions. The moves announced Wednesday promise ...

Eli Lilly (LLY-1.14%) took another big swipe at America's rebate-hungry reimbursement system by launching a generic competitor for two more of its popular insulin lispro containing products. Diabetes ...

GREENSBORO, N.C. — The headline reads, “Lilly cuts insulin prices by 70% and caps patient insulin out-of-pocket costs at $35 per month”. It's a great headline for millions of people. There are two ...